SCHEMBL6300562

SCHEMBL6300562

O=C(OC(=O)C(F)(F)F)c1cccc(-c2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.51
MAPT P10636 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
HDAC8 Q9BY41 1/20 0.47
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
ERCC5 P28715 1/20 0.44
FEN1 P39748 1/20 0.44
PDK2 Q15119 1/20 0.43
CES1 P23141 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
PRSS1 P07477 1/20 0.42
PRSS2 P07478 1/20 0.42
PRSS3 P35030 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA5 P31644 1/20 0.42
GABRA3 P34903 1/20 0.42
PTPN1 P18031 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27658519 0.85 PDCD1 (0.50) MAPTHDAC8HDAC1HDAC2CES1
SCHEMBL7654507 0.84 KMO (0.64) KMOMAPTTDP1HDAC8ERCC5
SCHEMBL271808 0.84 CES1 (0.54) MAPTTDP1CES1NPC1RAB9A
SCHEMBL29706640 0.84 KMO (0.64) KMOMAPTTDP1HDAC8ERCC5
SCHEMBL28286804 0.83 CES1 (0.52) MAPTTDP1CES1NPC1RAB9A
SCHEMBL27668613 0.80 KMO (0.55) KMOMAPTTDP1HDAC8HDAC1
SCHEMBL29365486 0.80 KMO (0.55) KMOMAPTTDP1HDAC8HDAC1
Trifluoroacetic Acid SCHEMBL27749215 0.79 PDK2 (0.57) KMOMAPTTDP1HDAC8PDK2
SCHEMBL5672271 0.79 PARP1 (0.49) MAPTTDP1ERCC5FEN1NPC1
SCHEMBL29287804 0.78 MAPT (0.63) KMOMAPTTDP1HDAC8ERCC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101360716-A Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia ASTRAZENECA AB (SE) 2009-02-04 CN claimed
CN-101360716-A Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer s disease, neurodegeneration and dementia ASTRAZENECA AB (SE) 2009-02-04 CN disclosed
US-6916837-B2 Amidino derivatives and anticoagulants and thrombosis therapeutic agents containing them EISAI CO., LTD. (JP) 2005-07-12 US disclosed